In comparison to patients with lower levels of serum albumin (<37.4 g/L), the adjusted odds ratio (OR) for severe impairment of ADL after stroke for those in the second quartile (Q2: 37.4–40.21 g/L), third quartile (Q3: 40.21–42.80 g/L), and fourth quartile (Q4: >42.8 g/L) were 0.68 (95% confidence interval [CI]: 0.40–1.15, p = 0.148), 0.55 (95% CI: 0.32–0.97, p = 0.04), and 0.65 (95% CI: 0.37–1.15, p = 0.139), respectively (Table 2). The gene discussed is ALB; the disease is stroke disorder.